Economic Research-Ekonomska Istraživanja, Volume 30, 2017 – Issue 1 (Open access)
Different shades of World Trade Organization (WTO) agreement on trade-related intellectual property rights (TRIPS) are reflected in the Indian pharmaceutical industry, but small and medium-scale pharmaceutical firms are slowly increasing their product innovation, process innovation and research and development (R&D) intensity. Analysis of variance results highlight a significant difference in performance of sole proprietorship/partnership, private limited and public limited firms vis-à-vis product innovation, process innovation, increased range of goods and services, R&D intensity, new technology adoption and adaptation. Factor analysis results indicated that developing intellectual property rights (IPR), technological measures and marketing practices explained 80.256% of variation. Policy initiative factor is dominating and SMEs are still relying heavily on support from government.
url – http://www.tandfonline.com/doi/full/10.1080/1331677X.2017.1311223
Courtesy – T&F